Enhancing HIV testing yield in southern Mozambique: the effect of a Ministry of Health training module in targeted provider-initiated testing and counselling

Anna Saura-Lázaro; Sheila Fernández-Luis; Tacilta Nhampossa; Laura Fuente-Soro; Elisa López-Varela; Edson Bernardo; Orvalho Augusto; Teresa Sánchez; Paula Vaz; Stanley C. Wei; Peter Kerndt; Nely Honwana; Peter Young; Guita Amane; Fernando Boene; Denise Naniche

doi:10.1101/2023.09.25.23296036

Abstract

Background In Mozambique, targeted provider-initiated HIV testing and counselling (PITC) is recommended to increase HIV testing yield where universal PITC is not feasible. However, its effectiveness depends on healthcare providers’ training. We evaluated the effect of a Ministry of Health training module in targeted PITC on the HIV testing yield.

Methods We conducted a single-group pre-post study between November 2018 and November 2019 in the triage and emergency departments of four healthcare facilities in Manhiça District. It consisted of two two-month phases split by a one-week targeted PITC training module (“observation phases”). During both phases, providers reported their recommendation to test or not for individuals ≥15 years, and study HIV counsellors performed universal testing. We calculated HIV testing yield of targeted PITC as the proportion of HIV-positive individuals among those provider-recommended and tested. We compared pre- and post-training yields using two-proportion z-test. Additionally, we extracted aggregated health information system data over the four months preceding and following the observation phases to compare yield in real-world conditions (“routine phases”). We used logistic regression to identify predictors of HIV test positivity.

Results Among 7,102 participants in the pre- and post-training observation phases (58.5% and 41.5% respectively), 68% were women, and 96% were recruited at triage. While HIV testing yield between pre- and post-training observation phases was similar, we observed an increase in yield in the post-training routine phase for women in triage (Yield ratio=1.54; 95%CI: 1.11-2.14). Age (25-49 years) (OR=2.43; 95%CI: 1.37-4.33), working in industry/mining (OR=4.94; 95%CI: 2.17-11.23), unawareness of partner’s HIV status (OR=2.50; 95%CI: 1.91-3.27), and visiting a healer (OR=1.74; 95%CI: 1.03-2.93) were factors associated with HIV test positivity. Including these factors in the targeted PITC algorithm could increase new HIV diagnoses by 2.6%. Furthermore, testing individuals with ≥1 HIV risk factor/symptom and a negative HIV test within the past three months revealed an additional 3.5% of undiagnosed PLHIV.

Conclusions We found over 50% increase in the HIV testing yield of targeted PITC among women in the four months following the training and observation phases. Including additional sociodemographic and risk factors in the targeted PITC algorithm could help identify undiagnosed PLHIV.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This publication has been supported by the President Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of NU2GGH002092, the Severo Ochoa predoctoral fellowship by the Barcelona Institute of Global Health (ISGlobal) to ASL, the predoctoral fellowship from the Secretariat of Universities and Research, Ministry of Enterprise and Knowledge of the Government of Catalonia and cofounded by European Social Fund to ASL and SFL, and the European Respiratory Society (ERS) and the European Union (EU) H2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement [847462] to ELV (This publication reflects only the view of the authors. The ERS, Research Executive Agency and EU are not responsible for any use that may be made of the information it contains). SW, employed by CDC participated in the conceptualization, study design and manuscript revision. For the remaining authors, none were declared. The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the funding agencies.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Mozambican MoH Institutional review board (IRB) (Approval Nr. 363/CNBS/18), the Centro de Investigacao em Saude de Mahica IRB (Approval Nr. CIBS-CISM/010/2018) and the Hospital Clinic Barcelona IRB (Approval Nr. HCB/2019/0379) and reviewed according to Centers for Disease Control and Prevention human research protection procedures (Approval Nr. 009F3EB81AA4251). All study participants, both healthcare providers and individuals presenting at the healthcare facilities, completed IC. For participants aged 15-18 years, a parent/legal representative's additional consent was necessary.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

The datasets generated and analysed during the current study are not publicly available due to privacy or ethical restrictions but are available from the corresponding author on reasonable request.